Nasdaq · CIK 0002104204
ALMR Alamar Biosciences, Inc.
Insider trading from SEC Form 4. Last filing 27 d ago. Close $25.27 on Oct 9, 2026, +32% from the 52-week low and -34% from the high.
Alamar Biosciences, Inc. (ALMR) has 11 SEC Form 4 filings on file from 11 insiders, the latest filed on Sep 16, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
2 open-market trades have been scored at ALMR. The newest: Illumina Innovation Fund II GP, L.L.C. (10% owner) bought $4.0M of stock on Apr 20, 2026, filed Apr 20, 2026, scored 50 (moderate). 2 insiders bought within 14 days of each other around Apr 20, 2026.
ALMR closed at $25.27 on Oct 9, 2026, 32% above its 52-week low and 34% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Alamar Biosciences, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Illumina Innovation Fund II GP, L.L.C. owner buy | $4.0M 235,294 shares | +87% | - | |
| 58Moderate | Nicholas Naclerio director buy | $4.0M 235,294 shares | +87% | - |
Transactions
The newest 50 of 124 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | John L. Brottem General Counsel | AGrant or award Common Stock | +29,000 | $0.00 | $0 | 29,000 | 27 d ago |
| Sep 14, 2026 | John L. Brottem General Counsel | AGrant or award Employee Stock Option (right to buy)derivative | +85,000 | $0.00 | $0 | 85,000 | 27 d ago |
| Sep 1, 2026 | Robert P Ragusa director | AGrant or award Common Stock | +5,686 | $0.00 | $0 | 5,686 | 40 d ago |
| Sep 1, 2026 | Robert P Ragusa director | AGrant or award Stock Option (Right to Buy)derivative | +25,599 | $0.00 | $0 | 25,599 | 40 d ago |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Class B Common Stockindirect: See footnote | +185,163 | - | - | 185,163 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Class B Common Stockindirect: See footnote | +6,881,410 | - | - | 6,881,410 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Class B Common Stockindirect: See footnote | +1,605,645 | - | - | 1,605,645 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Class B Common Stockindirect: See footnote | +1,922,329 | - | - | 1,922,329 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | JOther Class B Common Stockindirect: See footnote | -185,163 | - | - | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | JOther Class B Common Stockindirect: See footnote | -6,881,410 | - | - | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | JOther Class B Common Stockindirect: See footnote | -1,605,645 | - | - | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | JOther Class B Common Stockindirect: See footnote | -1,922,329 | - | - | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | JOther Common Stockindirect: See footnote | +185,163 | - | - | 185,163 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | JOther Common Stockindirect: See footnote | +6,881,410 | - | - | 6,881,410 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | JOther Common Stockindirect: See footnote | +1,605,645 | - | - | 1,605,645 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | JOther Common Stockindirect: See footnote | +1,922,329 | - | - | 1,922,329 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Series A-3 Preferred Stockderivativeindirect: See footnote | -172,328 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Series A-3 Preferred Stockderivativeindirect: See footnote | -6,404,332 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Series A-4 Preferred Stockderivativeindirect: See footnote | -154,425 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Series A-4 Preferred Stockderivativeindirect: See footnote | -5,738,971 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Series B Preferred Stockderivativeindirect: See footnote | -113,625 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Series B Preferred Stockderivativeindirect: See footnote | -4,222,738 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Series C Preferred Stockderivativeindirect: See footnote | -3,882,451 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Qiming Corporate GP VI, Ltd. owner | CConversion Series C Preferred Stockderivativeindirect: See footnote | -4,648,194 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | Yuling Luo Chief Executive Officer | CConversion Class B Common Stock | +1,386,746 | - | - | 1,499,797 | Apr 20, 2026 |
| Apr 20, 2026 | Frank Witney director | JOther Stock Option (Right to Buy)derivative | -49,627 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | Justin J. McAnear Chief Financial Officer | AGrant or award Common Stock | +37,220 | $0.00 | $0 | 37,220 | Apr 20, 2026 |
| Apr 20, 2026 | Rebecca Chambers director | JOther Stock Option (Right to Buy)derivative | -140,612 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | Timothy Ogden White President | JOther Class B Common Stock | -454,583 | - | - | 0 | Apr 20, 2026 |
| Apr 20, 2026 | Illumina Innovation Fund II GP, L.L.C. owner | CConversion Class B Common Stockindirect: See footnote | +4,588,364 | - | - | 4,588,364 | Apr 20, 2026 |
| Apr 20, 2026 | Nicholas Naclerio director | CConversion Class B Common Stockindirect: See footnote | +4,588,364 | - | - | 4,588,364 | Apr 20, 2026 |
| Apr 20, 2026 | Shiping Chen Chief Operating Officer | CConversion Class B Common Stock | +320,511 | - | - | 650,032 | Apr 20, 2026 |
| Apr 20, 2026 | Yuling Luo Chief Executive Officer | CConversion Class B Common Stock | +364,268 | - | - | 1,864,065 | Apr 20, 2026 |
| Apr 20, 2026 | Shiping Chen Chief Operating Officer | CConversion Class B Common Stock | +72,853 | - | - | 722,885 | Apr 20, 2026 |
| Apr 20, 2026 | Nicholas Naclerio director | CConversion Class B Common Stockindirect: See footnote | +922,152 | - | - | 5,510,516 | Apr 20, 2026 |
| Apr 20, 2026 | Frank Witney director | JOther Stock Option (Right to Buy)derivative | +49,627 | $0.00 | $0 | 49,627 | Apr 20, 2026 |
| Apr 20, 2026 | Rebecca Chambers director | JOther Stock Option (Right to Buy)derivative | +140,612 | $0.00 | $0 | 140,612 | Apr 20, 2026 |
| Apr 20, 2026 | Timothy Ogden White President | JOther Common Stock | +454,583 | - | - | 454,583 | Apr 20, 2026 |
| Apr 16, 2026 | Justin J. McAnear Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +163,358 | $0.00 | $0 | 163,358 | Apr 20, 2026 |
| Apr 20, 2026 | Illumina Innovation Fund II GP, L.L.C. owner | CConversion Class B Common Stockindirect: See footnote | +922,152 | - | - | 5,510,516 | Apr 20, 2026 |
| Apr 20, 2026 | Justin J. McAnear Chief Financial Officer | JOther Stock Option (Right to Buy)derivative | -570,719 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | Frank Witney director | JOther Stock Option (Right to Buy)derivative | -33,085 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | Timothy Ogden White President | AGrant or award Common Stock | +37,220 | $0.00 | $0 | 491,803 | Apr 20, 2026 |
| Apr 20, 2026 | Shiping Chen Chief Operating Officer | JOther Class B Common Stock | -722,885 | - | - | 0 | Apr 20, 2026 |
| Apr 20, 2026 | Nicholas Naclerio director | JOther Class B Common Stockindirect: See footnote | -5,510,516 | - | - | 0 | Apr 20, 2026 |
| Apr 20, 2026 | Yuling Luo Chief Executive Officer | JOther Class B Common Stock | -1,864,065 | - | - | 0 | Apr 20, 2026 |
| Apr 20, 2026 | Illumina Innovation Fund II GP, L.L.C. owner | JOther Class B Common Stockindirect: See footnote | -5,510,516 | - | - | 0 | Apr 20, 2026 |
| Apr 20, 2026 | Yuling Luo Chief Executive Officer | JOther Common Stock | +1,864,065 | - | - | 1,864,065 | Apr 20, 2026 |
| Apr 20, 2026 | Illumina Innovation Fund II GP, L.L.C. owner | JOther Common Stockindirect: See footnote | +5,510,516 | - | - | 5,510,516 | Apr 20, 2026 |
| Apr 20, 2026 | Justin J. McAnear Chief Financial Officer | JOther Stock Option (Right to Buy)derivative | +570,719 | $0.00 | $0 | 570,719 | Apr 20, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- John L. BrottemGeneral Counsel
- Rebecca Chamberscfo, officer, director
- Shiping ChenChief Operating Officer
- Illumina Innovation Fund II GP, L.L.C.owner
- Yuling LuoChief Executive Officer
- Justin J. McAnearChief Financial Officer
- Nicholas Naclerioowner, director
- Qiming Corporate GP VI, Ltd.owner
- Robert P Ragusaceo, officer, director
- Timothy Ogden WhitePresident
- Frank Witneydirector
Questions about ALMR
Answered from the filings on this page, as of the latest one.
Are insiders buying ALMR?
No. In the last 90 days no insider at Alamar Biosciences, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade ALMR on the open market?
Illumina Innovation Fund II GP, L.L.C. (10% owner) bought $4.0M of ALMR on Apr 20, 2026 and filed the Form 4 on Apr 20, 2026. InsiderTell scored 50 (moderate), with 2 insiders on the same side within 14 days.
How many insiders file Form 4 at Alamar Biosciences, Inc.?
11 people have filed a Form 4 at Alamar Biosciences, Inc., among them John L. Brottem (General Counsel), Rebecca Chambers (CFO and director), Shiping Chen (Chief Operating Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.